Atlas Trials

Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

Clinical trial NCT06945978 · RECRUITING

Trial details

NCT number
NCT06945978
Sponsor
Benedito Mauro Rossi
Status
RECRUITING
Study type
OBSERVATIONAL
Pancreatic CancerMetastasisEpigenetic
Start date
2025-01-21
Primary completion
2027-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.